{
    "moduleId": "module_22",
    "moduleTitle": "L2: Ethical Considerations",
    "passingScore": 80,
    "questions": [
        {
            "id": "q22_1",
            "question": "In the bioethical framework of Integrative Medicine, which principle is prioritized when a practitioner respects a patient's decision to refuse a high-evidence conventional treatment in favor of a low-evidence natural therapy, provided the patient is fully informed?",
            "options": [
                "Beneficence",
                "Non-maleficence",
                "Autonomy",
                "Justice"
            ],
            "correctAnswer": 2,
            "explanation": "Autonomy refers to the patient's right to self-determination and to make decisions about their own healthcare, even if those decisions conflict with the practitioner's recommendations."
        },
        {
            "id": "q22_2",
            "question": "The 'Materiality Standard' in advanced informed consent (as established in Canterbury v. Spence) dictates that a practitioner must disclose:",
            "options": [
                "Every possible risk associated with a treatment, no matter how rare.",
                "Only the risks that other practitioners in the same field would disclose.",
                "Information that a 'reasonable person' in the patient’s position would find significant to their decision.",
                "Only the risks that have a greater than 5% occurrence rate."
            ],
            "correctAnswer": 2,
            "explanation": "The Materiality Standard shifts the focus from what the doctor thinks is important to what a reasonable patient would want to know to make an informed choice."
        },
        {
            "id": "q22_3",
            "question": "A practitioner who recommends a high-dose vitamin protocol that interferes with a patient's chemotherapy may be held to the 'Standard of Care.' In legal terms, how is this standard typically defined for Integrative Practitioners?",
            "options": [
                "By the standards of the specific alternative modality only.",
                "By what a reasonably competent practitioner in the same field would do under similar circumstances.",
                "By the total absence of any side effects.",
                "By the personal success rate of the individual practitioner."
            ],
            "correctAnswer": 1,
            "explanation": "The 'Standard of Care' is a legal benchmark defined by the conduct of a reasonably competent peer in the same specialty under similar circumstances."
        },
        {
            "id": "q22_4",
            "question": "The Genetic Information Nondiscrimination Act (GINA) of 2008 provides federal protection against discrimination based on genetic data in which of the following areas?",
            "options": [
                "Life insurance and long-term care insurance.",
                "Health insurance and employment.",
                "Mortgage lending and educational admissions.",
                "Disability insurance and health insurance."
            ],
            "correctAnswer": 1,
            "explanation": "While GINA protects against discrimination in health insurance and employment, it notably does NOT cover life, disability, or long-term care insurance."
        },
        {
            "id": "q22_5",
            "question": "To maintain financial bioethics when selling supplements in-office, the Integrative Medicine Consortium recommends which of the following actions?",
            "options": [
                "Marking up products by at least 100% to cover consultation time.",
                "Only selling products that cannot be found elsewhere.",
                "Providing a written disclosure of the financial interest and informing patients they can purchase elsewhere.",
                "Requiring supplement purchases as a condition of remaining in the practice."
            ],
            "correctAnswer": 2,
            "explanation": "Disclosure and offering choice are the primary methods to mitigate the conflict of interest inherent in selling products to one's own patients."
        },
        {
            "id": "q22_6",
            "question": "How does 'Cultural Humility' differ from 'Cultural Competence' in a clinical setting?",
            "options": [
                "Cultural Humility is a mastery of the facts regarding different ethnic groups.",
                "Cultural Humility focuses on a lifelong commitment to self-evaluation and addressing power imbalances.",
                "Cultural Competence is only required for international practitioners.",
                "There is no difference; the terms are synonymous in medical ethics."
            ],
            "correctAnswer": 1,
            "explanation": "Unlike 'competence,' which implies an endpoint of mastery, 'humility' is a process of self-reflection and acknowledging the patient as the expert on their own experience."
        },
        {
            "id": "q22_7",
            "question": "Which of the following claims on a practitioner's website would most likely violate FTC and FDA regulations regarding 'Structure/Function' claims?",
            "options": [
                "‘Supports healthy inflammatory pathways.’",
                "‘Maintains optimal cognitive function during aging.’",
                "‘Clinically proven to treat and cure clinical depression.’",
                "‘Promotes digestive regularity.’"
            ],
            "correctAnswer": 2,
            "explanation": "Supplements and marketing cannot claim to 'treat, cure, prevent, or diagnose' a specific disease (like clinical depression) without being regulated as a drug."
        },
        {
            "id": "q22_8",
            "question": "In the context of complex chronic disease, the 'Ethics of Hope' requires a practitioner to:",
            "options": [
                "Always provide a positive prognosis to keep the patient's spirits up.",
                "Balance the psychological benefits of hope with the ethical duty of veracity (truth-telling).",
                "Avoid discussing end-of-life options until the patient is in a crisis.",
                "Recommend every possible experimental treatment regardless of cost."
            ],
            "correctAnswer": 1,
            "explanation": "Practitioners must provide 'honest hope'—supporting the patient's goals while remaining grounded in the reality of the clinical data."
        },
        {
            "id": "q22_9",
            "question": "When interpreting functional lab testing, 'Clinical Utility' refers to:",
            "options": [
                "How accurately the test measures the specific analyte.",
                "Whether the test results lead to a change in management that improves patient outcomes.",
                "The cost of the test relative to conventional labs.",
                "The percentage of false positives generated by the test."
            ],
            "correctAnswer": 1,
            "explanation": "Clinical utility is the most important ethical consideration in testing—it asks if the test actually helps the patient get better or change their treatment for the better."
        },
        {
            "id": "q22_10",
            "question": "A practitioner who fails to coordinate care with a patient's oncologist, leading to a dangerous herb-drug interaction, has primarily breached the ethical duty of:",
            "options": [
                "Interprofessional Collaboration and Patient Safety.",
                "Financial Stewardship.",
                "Marketing Integrity.",
                "Genetic Privacy."
            ],
            "correctAnswer": 0,
            "explanation": "Practitioners have an ethical (and often legal) duty to collaborate with other members of the patient's healthcare team to ensure safety and continuity of care."
        }
    ]
}